Bacillus amyloliquefancies CH51 isolated from cheonggukjang, a traditional Korean fermented soy food, has strong fibrinolytic activity and produces several fibrinolytic enzymes. Among four different growth media, tryptic soy broth was the best in terms of supporting cell growth and fibrinolytic activity of this strain. A protein with fibrinolytic activity was partially purified from the culture supernatant by CMSephadex and Phenyl Sepharose column chromatographies. Tandem mass spectrometric analysis showed that this protein is a homolog of AprE from B. subtilis and it was accordingly named AprE51. The optimum pH and temperature for partially purified AprE51 activity were 6.0 and 45 o C, respectively. A gene encoding AprE51, aprE51, was cloned from B. amyloliquefaciens CH51 genomic DNA. The aprE51 gene was overexpressed in heterologous B. subtilis strains deficient in fibrinolytic activity using an E. coli-Bacillus shuttle vector, pHY300PLK.
Strains of Bacillus amyloliquefaciens are some of the most common bacilli isolated from fermented soybean foods. Some of these strains possess fibrinolytic activity [4, 18] conferred by certain proteolytic enzymes that are secreted by the bacilli, nattokinase being the most well-known example [20] . Fibrinolytic enzymes are able to resolve fibrin clots, thus being responsible for an important functionality of soybean foods fermented by bacilli.
Cheonggukjang, a traditional Korean fermented soy food, is an important source of bacilli with fibrinolytic activity [11] . In traditional cheonggukjang preparation, cooked soybeans are covered with rice straw, which is a rich source of Bacillus spores. During fermentation for 2 or 3 days at around 40 o C, soybean proteins are digested, releasing oligopeptides and amino acids. In some cases, sticky materials are produced on the surface of the soybeans. After fermentation, cheonggukjang is usually served as a side dish with rice after being boiled with other seasonings, such as garlic and pepper.
Cheonggukjang is known to possess several healthpromoting properties, such as anticancer activity, abilities to lower blood pressure and prevent myocardial and cerebral infarction, antioxidant activity, and probiotic activity [15] .
B. amyloliquefaciens CH51, previously isolated from cheonggukjang, showed higher fibrinolytic activity than other isolates when examined by the fibrin plate method [9] . It produces several fibrinolytic enzymes (see Fig. 1 ) but these have not yet been characterized. In an effort to understand the fibrinolytic system of B. amyloliquefaciens CH51, we attempted to purify fibrinolytic enzymes from its culture supernatants. As a result, the major fibrinolytic enzyme, AprE51 was partially purified, its properties were examined, and its structural gene was cloned.
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions B. amyloliquefaciens CH51 was previously isolated from cheonggukjang and identified by molecular methods including 16S rRNA gene and recA sequencing [12] .
B. amyloliquefaciens CH51 was grown in tryptic soy broth (TSB; Becton, Dickinson and Company, Sparks, MD, U.S.A.) or LB at 37 o C with aeration. Nutrient broth (NB) and brain heart infusion (BHI) were used for comparision. E. coli and B. subtilis strains were grown in LB at 37 o C with shaking. Cells containing pHY300PLK (Takara, Shiga, Japan) or pHY51 were cultivated in LB supplemented with 10 µg/ml tetracycline (LBTc).
Assay of Fibrinolytic Activity
Bacillus cells were cultivated in TSB at 37 o C with shaking. At the appropriate growth stage, the culture was centrifuged at 5,000 ×g for 20 min at 4 o C. The supernatant was filtered and assayed for fibrinolytic activity. If necessary, the supernatant was further concentrated by ammonium sulfate precipitation (80%, w/v). The ammonium sulfate pellet was redissolved in a small volume of buffer A (20 mM TrisHCl, pH 7.0). Protein concentration was determined according to the Bradford method [2] using bovine serum albumin (BSA) as a standard.
Fibrinolytic activity was determined using the fibrin plate method [1] . In a Petri dish, 7 ml of 1.2% (w/v) fibrinogen (Sigma, St. Louis, MO, U.S.A.) solution in 1 M phosphate-buffered saline (PBS) was mixed with an equal volume of 2% (w/v) agarose solution along with 0.1 ml of thrombin solution (100 NIH units/ml; Sigma). The Petri dish was left at room temperature for 1 h to allow a fibrin clot layer to form. Twenty µl of sample was dropped into a hole that had been made in a fibrin plate using a capillary glass tube, and the plate was incubated at 37 o C for 6 h. The size of the clear zone that formed was converted into plasmin units (U) by comparing it to zones formed by known quantities of plasmin. A standard curve showing the relationship between the area of the clear zone formed and the number of plasmin units was prepared in the range of 1.5-30 mU.
SDS-PAGE and Fibrin Zymography
Culture supernatant was concentrated by ammonium sulfate precipitation (80%, w/v), and then the pellet was resuspended in a small volume of buffer A and dialyzed against the same buffer for 24 h at 4 o C with four buffer changes. SDS-PAGE was performed according to Laemmli's method [13] , and fibrin zymography was carried out as previously described [6, 10] . The separating gel solution (12%, w/v) contained fibrinogen (0.12%, w/v) and 100 µl of thrombin (10 NIH units/ml).
Partial Purification of AprE51
Culture supernatant (1 l) was concentrated by ammonium sulfate precipitation (80%, w/v). The precipitate was resuspended in 10 ml of buffer A and then dialyzed against 20 volumes of the same buffer for 24 h with four buffer changes. The protein sample was loaded onto a CM-Sephadex (Amersham Pharmacia Biotech, Uppsala, Sweden) column (2.5×8 cm), and proteins were eluted by sequential application of six 200-ml volumes of buffer A containing NaCl at a concentration of 0 to 1 M, increased stepwise in 0.2 M increments. Twenty µl of each 15-ml fraction was spotted onto a fibrin plate. Fractions showing fibrinolytic activity were pooled, dialyzed against buffer A, and then lyophilized. Hydrophobic interaction chromatography using Phenyl Sepharose 6 Fast Flow (Amersham Pharmacia Biotech, Uppsala, Sweden) was used for further purification. The column (2.5×12 cm) was washed and pre-equilibrated with buffer A containing 1 M (NH at a concentration of 1 to 0 M, decreased stepwise in 0.2 M increments. Active 15 ml fractions were pooled, dialyzed against buffer A, and lyophilized prior to analysis by SDS-PAGE and zymography. Protein bands were excised from the stained SDS gel. Trypsin digestion and mass spectrometric analysis of peptides were performed at Genomine (Pohang, Gyungbuk, Korea).
Properties of Partially Purified AprE51
Effects of pH, temperature, metal ions, and inhibitors on the fibrinolytic activity of AprE51 were examined by the fibrin plate method. Eight mg of AprE51 was incubated in either 0.1 M citrateNaOH buffer ( 
Cloning of the aprE51 Gene
The primer pair CH51-F (5'-AGGATCCCAAGAGAGCGATTGCG GCTGTGTAC-3', BamHI site underlined) and CH51-R (5'-AGAAT TCTTCAGAGGGAGCCACCCGTCGATCA-3', EcoRI site underlined), was designed based on the sequence of aprE (Accession No. CP000560.1) from B. amyloliquefaciens FZB42. PCR was performed using a GeneAmp 2400 PCR system (PerkinElmer, Waltham, MA, U.S.A.). The reaction mixture (50 µl) contained 1 ml of template DNA, 1 µl of each primer (10 µM), 1 µl of deoxynucleoside triphosphates (0.25 mM), and 0.5 µl of ExTaq DNA polymerase (Takara, Shiga, Japan). The amplification conditions were as follows: 94 and E. coli DH5α cells were transformed with the ligation mixture. Preparation and electroporation of E. coli competent cells were performed as previously described [9] . Plasmid DNA preparation, restriction enzyme digestion, and agarose gel electrophoresis were performed according to published methods [19] .
Overexpression of aprE51 in Protease-Deficient B. subtilis Strains aprE51 was amplified using primer pair CH51-F and CH51-R, and then digested with BamHI and EcoRI. The 1.5 kb fragment was ligated into pHY300PLK, resulting in pHY51. Preparation and electroporation of Bacillus competent cells were carried out as previously described [9] . B. subtilis WB600 [21] and ISW 1214 (Takara) were used as hosts for aprE51 gene expression. B. subtilis transformants (TFs) were grown in LBTc at 37 o C for 2 days. Cells were recovered by centrifugation at 5,000 ×g for 20 min at 4 o C and the supernatant was used for the enzyme assay.
For SDS-PAGE and zymography, protein samples were prepared from B. subtilis TFs using different methods. Culture supernatant was mixed with an equal volume of cold 20% (w/v) trichloroacetic acid (TCA) solution and kept on ice for 15 min prior to centrifugation [7] . The protein pellet was washed four times with 100% ethyl alcohol, dried, and then resuspended in 50 mM Tris-HCl (pH 7.4). Ten µg of protein was subjected to SDS-PAGE (12% acrylamide) as described above. For zymography, the supernatant was concentrated by ammonium sulfate precipitation (80%, w/v) and 1 mg was applied to the gel.
RESULTS AND DISCUSSION
Fibrinolytic Activity of B. amyloliquefaciens CH51 We previously isolated bacilli exhibiting fibrinolytic activity from cheonggukjang prepared by traditional methods in Sunchang County, North Jeolla Province, Korea [12] . Among these strains, CH51 and CH86-1, which were identified as B. amyloliquefaciens, showed the highest fibrinolytic activities. Analysis of culture supernatant by zymography on a fibrin gel revealed that B. amyloliquefaciens CH51 produces 6 fibrinolytic enzymes (see Fig. 1, lane 3) . Distinct bands with sizes of 70, 66, 50, 32, and 27 kDa were observed. In addition, a large smear was observed at the top of the separating gel. The smear was caused by either binding of fibrinolytic enzymes to fibrin in the gel [14] or by their high pI values [4] , which could have prevented them from migrating to the points in the gel that correspond to their molecular masses. It will be necessary to characterize each component of the fibrinolytic system and evaluate the contribution of each enzyme to the observed fibrinolytic activity of B. amyloliquefaciens CH51 if this strain is to be fully utilized for the production of functional foods or medicines.
The growth and fibrinolytic activity of B. amyloliquefaciens CH51 in four different media were compared. Each medium was inoculated with 2% (w/v) overnight culture and incubated at 37 o C with shaking. Growth in TSB showed the best result, reaching an absorbance value of 1.9 by the end of cultivation at 48 h (Fig. 2) . Growth in other media was less efficient than in TSB, reaching about 1.5. Cells grown in TSB showed the highest fibrinolytic activity, followed by those grown in NB and LB. Interestingly, cells did not show any significant fibrinolytic activity when grown in BHI although the medium supported cell growth as well as NB and LB did (Fig. 2) . This result, the cause of which is unknown, indicates that the choice of growth medium and possibly cultivation conditions are important for the production of fibrinolytic enzymes by B. amyloliquefaciens CH51.
Partial Purification of AprE51
Fibrinolytic enzymes in the culture supernatant were purified by CM-Sephadex and Phenyl-Sepharose column chromatographies. A fibrin plate assay was used to detect active fractions. Purification results are summarized in Table 1 and the overall purification was 20.3-fold. When active fractions from the Phenyl-Sepharose column were pooled •, BHI; ○, LB; ▼ , NB; ▽, TSB. Filtered culture supernatant (20 µl) at each time point was applied to a fibrin plate and the fibrinolytic activity was expressed as U/ml. and examined by SDS-PAGE, four major bands (45, 27, 23, and 19 kDa in size), in addition to a few minor bands, were detected when the gel was stained with Coomassie blue (Fig. 3) . The four major bands were excised from the gel and subjected to trypsin digestion and mass spectrometric analysis. The 27 kDa protein (AprE51 in Fig. 3 ) was identified as a homolog of subtilisin DJ-4 from Bacillus sp. DJ-4 [5] , subtilisin DFE from B. amyloliquefaciens [18] , hypothetical protein AprE from B. amyloliquefaciens FZB42 (protein id=ABS73414), and AprE from B. subtilis (protein id=ABY83469).
These results confirmed that the 27 kDa protein is a subtilisin-type protease with fibrinolytic activity; it has been accordingly named AprE51. B. subtilis secretes several proteases into the culture medium, subtilisin being the most predominant [3] . Therefore, AprE51 is the major protease with fibrinolytic activity secreted by B. amyloliquefaciens CH51. The 23 kDa protein (BglS in Fig. 3 ) was identified as a β-1,3-1,4-endoglucanase precursor, and the 19 kDa protein (XynA in Fig. 3 ) as endo-1,4-beta-xylanhydrolase. The 45 kDa protein (YnfF in Fig. 3 ) might be a homolog of YnfF, a precursor of dimethyl sulfoxide reductase, from Bacillus species. Zymography results (Fig. 3B ) also support the conclusion that AprE51 is the major fibrinolytic enzyme of B. amyloliquefaciens CH51. In lane 4, two minor fibrinolytic enzymes were observed that were later removed by CM-Sephadex column chromatography. These minor fibrinolytic enzymes will need to be characterized in the future. Cultivation conditions for the production of fibrinolytic enzymes must be chosen carefully since they may affect the activity of each enzyme differently.
Properties of Partially Purified AprE51
The effects of pH, temperature, and metal ions on the fibrinolytic activity of AprE51 were examined using the fibrin plate method. The optimal pH was 6.0 (Fig. 4) (Table 2) . Among the metal ions tested, Cu
2+
showed the greatest inhibition (39.5%). PMSF, a well-known inhibitor of serine-type proteases, inhibited fibrinolytic activity by 66.6%. EDTA also inhibited the activity by 17%, indicating that inhibition of another minor protease, probably a metalloprotease, might be responsible for this loss of activity, even though its presence was not confirmed by SDS-PAGE.
Cloning and Sequencing of aprE51
The aprE51 gene encoding AprE51 was cloned from B. amyloliquefaciens CH51 genomic DNA by PCR. The amplified 1.5 kb DNA fragment was ligated into pGEM-T Easy Vector and introduced into E. coli DH5α cells. TFs harboring the recombinant plasmid pTaprE51 were obtained, and DNA sequencing confirmed that the cloned gene is indeed a homolog of aprE. The sequence was deposited in GenBank (Accession No. EU414203). Fig. 5 shows the translated amino acid sequence of AprE51 and its alignment with the sequences of other subtilisins. These proteins were found to be 99% identical to AprE51 when conservative amino acid substitutions are taken into consideration. When compared with AprE from B. amyloliquefaciens FZB42, AprE51 has four different amino acids, located at positions 26 (T in AprE51, S in AprE), 27 (S in AprE51, P in AprE), 105 (Q in AprE51, K in AprE), and 168 (N in AprE51, Y in AprE). Two changes are conservative (positions 26 and 105), leaving only two significant differences in amino acid sequence (99% positive matches) between the two proteins. AprE51 is synthesized as a preproprotein, as are all subtilisins. It consists of 382 amino acids, with the 107 amino acids at the N-terminus corresponding to the prepro sequence; tandem mass spectrometric results showed that the active 27 kDa protein sequence begins with AQS--, corresponding to position 108 of AprE51 as inferred from the nucleotide sequence (data not shown). The calculated molecular weight of the active enzyme is 27,446.57, which corresponds well to the SDS-PAGE result. The first 30 amino acids seem to constitute the prepeptide (signal peptide) when comparing the sequence to that of other homologous proteins. This signal peptide is longer than that of AprE2 from Bacillus subtilis CH3-5 by one amino acid [9] . Subtilisins BPN' and DJ-4 have signal peptides consisting of 30 amino acids, whereas subtilisins E [16] , NAT [17] , and J [8] have signal peptides consisting of 29 amino acids.
Although an active ca. 27 kDa band was observed on a zymogram of B. amyloliquefaciens CH51 culture supernatant (Fig. 1, lane 3) , it was not AprE51. Under nondenaturing conditions, AprE51 failed to migrate through the separating gel to the point corresponding to its size (27 kDa). When slices corresponding to the apparent molecular masses of 70 and 80 kDa were excised from the gel and analyzed by mass spectrometry, one band (80 kDa) turned out to be AprE51 (data not shown). When the eluted protein sample was analyzed by SDS-PAGE after boiling, a 27 kDa band appeared instead of an 80 kDa band (data not shown). These results indicate that, under nondenaturing conditions, AprE51 molecules are not resolved according to size but remain near the top of the acrylamide gel, forming a large smear; this behavior has also been reported for other subtilisins secreted by Bacillus species [3, 4] . The same result was obtained when aprE51 was overexpressed in heterologous B. subtilis hosts (see Fig. 6 B, lanes 3 and 6) . Zymography cannot clearly distinguish between each enzyme component, especially if their activity has been destroyed by denaturing samples in order to resolve protein components. In many cases, a large smear is observed at the top of a zymogram instead of individually separated active bands. More efficient methods of resolving fibrinolytic enzymes will certainly need to be developed in order to facilitate the understanding of the fibrinolytic capacity of bacilli.
Overexpression of aprE51 in Protease-Deficient B. subtilis Strains The PCR-amplified 1.5 kb aprE51 gene was ligated into pHY300PLK, generating pHY51, which was introduced into B. subtilis WB600 and ISW1214. Expression of aprE51 in these hosts was confirmed by SDS-PAGE and zymography (Fig. 6) . In Fig. 6A , an arrow on the right side of the gel indicates the position of AprE51, and the results show that only cells harboring pHY51 produced this protein. In B. subtilis WB600, a strain deficient in six extracellular proteases [21] , the lack of these proteases was probably responsible for the efficient production of AprE51. It is suspected that B. subtilis ISW1214 has a similar genetic background to WB600 since similar levels of aprE51 expression were observed in both strains (Fig. 6B) .
Results obtained for cell growth and fibrinolytic activity of B. subtilis TFs are summarized in Fig. 7 . The fibrinolytic activities of both B. subtilis TFs were lower than that of B. amyloliquefaciens CH51. It could be interpreted that AprE51 alone might not be sufficient for B. subtilis hosts to be as highly fibrinolytic as B. amyloliquefaciens CH51 because the latter synthesizes additional fibrinolytic enzymes. If aprE51 were to be overexpressed in B. amyloliquefaciens CH51 or B. amyloliquefaciens CH86-1, another highly fibrinolytic isolate, it might enhance the fibrinolytic activity of the host cells. It is desirable that each component of the fibrinolytic system of B. amyloliquefaciens CH51 be characterized and used for the construction of Bacillus strains with improved fibrinolytic activity.
